These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 8663015)
1. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. Praticò D; Smyth EM; Violi F; FitzGerald GA J Biol Chem; 1996 Jun; 271(25):14916-24. PubMed ID: 8663015 [TBL] [Abstract][Full Text] [Related]
2. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]
3. The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Minuz P; Andrioli G; Degan M; Gaino S; Ortolani R; Tommasoli R; Zuliani V; Lechi A; Lechi C Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1248-56. PubMed ID: 9714131 [TBL] [Abstract][Full Text] [Related]
4. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R; Mezzasoma AM; Venditti G; Gresele P Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439 [TBL] [Abstract][Full Text] [Related]
6. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2. Fukunaga M; Yura T; Grygorczyk R; Badr KF Am J Physiol; 1997 Apr; 272(4 Pt 2):F477-83. PubMed ID: 9140048 [TBL] [Abstract][Full Text] [Related]
8. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets. Astarie-Dequeker C; Korichneva I; Devynck MA Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751 [TBL] [Abstract][Full Text] [Related]
9. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. Kinsella BT; O'Mahony DJ; Fitzgerald GA J Pharmacol Exp Ther; 1997 May; 281(2):957-64. PubMed ID: 9152406 [TBL] [Abstract][Full Text] [Related]
11. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
12. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction. Johnson GJ; Leis LA; Dunlop PC J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362 [TBL] [Abstract][Full Text] [Related]
14. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
16. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets. Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308 [TBL] [Abstract][Full Text] [Related]
17. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets. Nakano T; Hanasaki K; Arita H J Biol Chem; 1989 Apr; 264(10):5400-6. PubMed ID: 2494164 [TBL] [Abstract][Full Text] [Related]
18. Different effects of two thromboxane A2/prostaglandin H2 receptor ligands, U46619 and S-145, on rabbit platelets. Nakano T; Hanasaki K; Arita H FEBS Lett; 1988 Jul; 234(2):309-12. PubMed ID: 2968921 [TBL] [Abstract][Full Text] [Related]
19. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Okwu AK; Mais DE; Halushka PV Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280 [TBL] [Abstract][Full Text] [Related]
20. Antiaggregatory effects of thromboxane receptor antagonists in vivo. Darius H; Lefer AM Thromb Res; 1985 Dec; 40(5):663-75. PubMed ID: 2935972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]